OS8.4 Impact of brain invasion assessment on outcome in intracranial grade II meningiomas

Tekijä Picart, T, Dumot, C, Ducray, F, Durand, A, Guyotat, J, Berhouma, M, Meyronet, D
Julkaisussa Neuro Oncol (2019)

P14.127 From next generation sequencing and comparative genomic hybridization to personalised medicine for adult primary brain tumors: the profiler trial

Tekijä Bonneville-levard, A, Frappaz, D, Pissaloux, D, Wang, Q, Perol, D, Blay, J, Meyronet, D
Julkaisussa Neuro Oncol (2019)

Spectral complexity of 5-ALA induced PpIX fluorescence in guided surgery: a clinical study towards the discrimination of healthy tissue and margin boundaries in high and low grade...

Tekijä Alston, L., Mahieu-Williame, L., Hebert, M., Kantapareddy, P., Meyronet, D., Rousseau, D., Guyotat, J., Montcel, B.
Julkaisussa Biomed Opt Express (2019)

P14.88 Comparison of SNaPshot PCR and digital droplet PCR for the identification of TERT promoter in non-diagnostic biopsies from glioma patients

Tekijä Poncet, D, Picart, T, Guyotat, J, Jouanneau, E, Joubert, B, Vasiljevic, A, Honnorat, J, Meyronet, D, Ducray, F, Barritault, M
Julkaisussa Neuro Oncol (2019)

P01.120 Importance of systematic TERT promoter and IDH mutations screening in non-diagnostic biopsies from patients​ with a suspected glioma

Tekijä Barritault, M, Picart, T, Poncet, D, Fenouil, T, Guyotat, J, Jouanneau, E, Joubert, B, Vasiljevic, A, Honnorat, J, Meyronet, D, Ducray, F
Julkaisussa Neuro Oncol (2018)

OS5.4 Characteristics of adult diffuse H3K27M-mutant gliomas at recurrence

Tekijä Hodroj, K, Meyronet, D, Barritault, M, Bourg, V, Cohen-Moyal, E, Cartalat, S, Ameli, R, Berhouma, M, Honnorat, J, Ducray, F
Julkaisussa Neuro Oncol (2019)

OS5.5 Characteristics of high-grade gliomas with H3 G34 mutation in adults

Tekijä Picart, T, Barritault, M, Tabouret, E, Idbaih, A, Izquierdo Gracia, C, Poncet, D, Honnorat, J, Meyronet, D, Guyotat, J, Ducray, F
Julkaisussa Neuro Oncol (2019)

P14.13 Incidence of pseudoprogression in high-grade IDH-mutant gliomas

Tekijä SEYVE, A, Cartalat, S, Meyronet, D, D’hombres, A, Barritault, M, Jouanneau, E, Berhouma, M, Guyotat, J, Honnorat, J, Ducray, F
Julkaisussa Neuro Oncol (2019)

P08.43 Bevacizumab discontinuation and bevacizumab re-challenge in glioblastoma patients

Tekijä Bonnet, C., Cartalat-Carel, S., Thomas, L., Joubert, B., Meyronet, D., D’Hombres, A., Jouanneau, E., Guyotat, J., Honnorat, J., Ducray, F.
Julkaisussa Neuro Oncol (2016)

P08.39 Characteristics of adults’ gliomas with H3-K27M mutations

Tekijä Esteban Mader, M., Bonnet, C., Meyronet, D., Joly, M., Uro-Coste, E., Forest, F., Guyotat, J., Jouvet, A., Honnorat, J., Ducray, F.
Julkaisussa Neuro Oncol (2016)

OS3.3 Radiological characteristics and natural history of adult IDH wild type astrocytomas with TERT promoter mutations

Tekijä Izquierdo, C, Barritault, M, Poncet, D, Cartalat, S, Joubert, B, Bruna, J, Jouanneau, E, Guyotat, J, Vasiljevic, A, Fenouil, T, Berthezène, Y, Honnorat, J, Meyronet, D, Ducray, F
Julkaisussa Neuro Oncol (2018)

P13.02 Conventional MRI radiomics in the diagnosis of early- and pseudo-progression

Tekijä Bani Sadr, A, Eker, O F, Berner, L, Ameli, R, Hermier, M, Barritault, M, Meyronet, D, Guyotat, J, Jouanneau, E, Honnorat, J, Ducray, F, Berthezène, Y
Julkaisussa Neuro Oncol (2019)